Form 8-K - Current report:
SEC Accession No. 0001493152-25-006890
Filing Date
2025-02-14
Accepted
2025-02-14 16:30:26
Documents
13
Period of Report
2025-02-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 25164
  Complete submission text file 0001493152-25-006890.txt   200041

Data Files

Seq Description Document Type Size
2 awh-20250211.xsd EX-101.SCH 3012
3 awh-20250211_lab.xml EX-101.LAB 34240
4 awh-20250211_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3817
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 25629658
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)